Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802.

被引：0
|
作者：
Saito, Ryota
Inoue, Akira
Sugawara, Shunichi
Oizumi, Satoshi
Maemondo, Makoto
Okudera, Koichi
Suzuki, Toshiro
Usui, Kazuhiro
Harada, Masao
Morikawa, Naoto
Hasegawa, YUkihiro
Ishimoto, Osamu
Sakakibara, Tomohiro
Asahina, Hajime
Nukiwa, Toshihiro
机构：
[1] Tohoku Univ Hosp, Sendai, Miyagi, Japan
[2] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[3] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan
[4] Miyagi Canc Ctr, Natori, Miyagi 9811293, Japan
[5] Hirosaki Chuo Hosp, Hirosaki, Aomori, Japan
[6] Iwate Isawa Hosp, Oushu, Japan
[7] Kanto Med Ctr NTT EC, Tokyo, Japan
[8] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[9] Tohoku Kosei Nenkin Hosp, Sendai, Miyagi, Japan
[10] Aomori Prefectural Cent Hosp, Aomori, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7086
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)
    Lovly, Christine Marie
    Li, Chung-I
    Hutchison, Anne Smith
    Carbone, David Paul
    Johnson, David H.
    Keedy, Vicki Leigh
    Pao, William
    Sandler, Alan
    Horn, Leora
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] PHASE II STUDY OF AMRUBICIN IN PATIENTS WITH REFRACTORY OR RESISTANT RELAPSED SMALL-CELL LUNG CANCER: JAPAN CLINICAL ONCOLOGY GROUP STUDY (JCOG0901)
    Daga, H.
    Murakami, H.
    Yamamoto, N.
    Shibata, T.
    Endo, M.
    Watanabe, H.
    Ichinose, Y.
    Yamamoto, N.
    Ohe, Y.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 492 - 492
  • [23] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)
    Venepalli, N. K.
    Hutchison, A. S.
    Carbone, D. P.
    Johnson, D. H.
    Keedy, V. L.
    Pao, W.
    Sandler, A.
    Horn, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] Phase II study of amrubicin, a new active drug in refractory or relapsed small-cell lung cancer (SCLC): Thoracic Oncology Research Group Trial 0301.
    Seto, T.
    Masuda, N.
    Takiguchi, Y.
    Isobe, H.
    Okamoto, H.
    Ogura, T.
    Yokoyama, A.
    Watanabe, K.
    Eguchi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [25] EFFICACY OF AMRUBICIN IN PATIENTS WITH REFRACTORY RELAPSED SMALL CELL LUNG CANCER
    Wakuda, Kazushige
    Kenmotsu, Hirotsugu
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Kimura, Madoka
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Shukuya, Takehito
    Taira, Tetsuhiko
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S493 - S494
  • [26] Epirubicin combined with ifosfamide in relapsed or refractory small cell lung cancer (SCLC) patients
    Jacot, William
    Molinier, Olivier
    Colinet, Benoit
    Bozonnat, Marie-Cecile
    Quantin, Xavier
    Gervais, Radj
    Pujol, Jean-Louis
    ANNALS OF ONCOLOGY, 2006, 17 : 232 - 233
  • [27] Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402
    Nogami, Naoyuki
    Hotta, Katsuyuki
    Segawa, Yoshihiko
    Takigawa, Nagio
    Hosokawa, Shinobu
    Oze, Isao
    Fujii, Masanori
    Ichihara, Eiki
    Shibayama, Takuo
    Tada, Atsuhiko
    Hamada, Noboru
    Uno, Masatoshi
    Tamaoki, Akihiko
    Kuyama, Shoichi
    Ikeda, Genyo
    Osawa, Masahiro
    Takata, Saburo
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    ACTA ONCOLOGICA, 2012, 51 (06) : 768 - 773
  • [28] Phase II study of topotecan in refractory and sensitive small cell lung cancer (SCLC)
    Ardizzoni, A
    Hansen, HH
    Dombernowsky, P
    Kaplan, S
    Postmus, PE
    Gamucci, T
    Schaefer, B
    Wanders, J
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 84 - 84
  • [29] Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic oncology research group study 0301
    Onoda, Sayaka
    Masuda, Noriyuki
    Seto, Takashi
    Eguchi, Kenji
    Takiguchi, Yuichi
    Isobe, Hiroshi
    Okamoto, Hiroaki
    Ogura, Takashi
    Yokoyama, Akira
    Seki, Nobuhiko
    Asaka-Amano, Yoshiko
    Harada, Masao
    Tagawa, Akihiro
    Kunikane, Hiroshi
    Yokoba, Masanori
    Uematsu, Kazutsugu
    Kuriyama, Takayuki
    Kuroiwa, Yumi
    Watanabe, Koshiro
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5448 - 5453
  • [30] A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer
    Inoue, Akira
    Yamazaki, Koichi
    Maemondo, Makoto
    Suzuki, Takuji
    Kimura, Yuichiro
    Kanbe, Mariko
    Isobe, Hiroshi
    Nishimura, Masaharu
    Saijo, Yasuo
    Nukiwa, Toshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 551 - 555
12345